PubRank

Robert Tibshirani

Author PubWeight™ 350.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003 88.64
2 Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 2003 34.68
3 Sparse inverse covariance estimation with the graphical lasso. Biostatistics 2007 24.38
4 Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A 2002 12.68
5 Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A 2004 10.99
6 Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A 2005 10.85
7 Empirical bayes methods and false discovery rates for microarrays. Genet Epidemiol 2002 10.56
8 Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004 9.81
9 A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis. Biostatistics 2009 9.40
10 Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol 2004 7.68
11 Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 2007 6.80
12 Comment on "The consensus coding sequences of human breast and colorectal cancers". Science 2007 5.88
13 Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer 2006 5.39
14 Cell type-specific gene expression differences in complex tissues. Nat Methods 2010 4.75
15 Statistical methods for identifying differentially expressed genes in DNA microarrays. Methods Mol Biol 2003 4.28
16 Regularized linear discriminant analysis and its application in microarrays. Biostatistics 2006 3.66
17 A framework for feature selection in clustering. J Am Stat Assoc 2010 3.46
18 Finding consistent patterns: a nonparametric approach for identifying differential expression in RNA-Seq data. Stat Methods Med Res 2011 3.44
19 Covariance-regularized regression and classification for high-dimensional problems. J R Stat Soc Series B Stat Methodol 2009 3.31
20 Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol 2002 2.87
21 A network model of a cooperative genetic landscape in brain tumors. JAMA 2009 2.86
22 A method for calling gains and losses in array CGH data. Biostatistics 2005 2.86
23 Genome-wide measurement of RNA folding energies. Mol Cell 2012 2.85
24 Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med 2005 2.56
25 Gene expression patterns in ovarian carcinomas. Mol Biol Cell 2003 2.55
26 Spectral Regularization Algorithms for Learning Large Incomplete Matrices. J Mach Learn Res 2010 2.45
27 Normalization, testing, and false discovery rate estimation for RNA-sequencing data. Biostatistics 2011 2.36
28 Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 2008 2.36
29 Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia 2005 2.35
30 Are clusters found in one dataset present in another dataset? Biostatistics 2006 2.33
31 Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood 2007 2.29
32 Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol 2012 2.12
33 Averaged gene expressions for regression. Biostatistics 2006 2.03
34 Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. Hepatology 2006 2.03
35 Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast Cancer Res 2005 2.00
36 Disease signatures are robust across tissues and experiments. Mol Syst Biol 2009 1.93
37 3'-end sequencing for expression quantification (3SEQ) from archival tumor samples. PLoS One 2010 1.91
38 Boolean implication networks derived from large scale, whole genome microarray datasets. Genome Biol 2008 1.91
39 A tail strength measure for assessing the overall univariate significance in a dataset. Biostatistics 2005 1.90
40 LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. J Clin Oncol 2007 1.88
41 Discovery and validation of breast cancer subtypes. BMC Genomics 2006 1.83
42 Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol 2010 1.80
43 The 'miss rate' for the analysis of gene expression data. Biostatistics 2005 1.71
44 An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res 2006 1.71
45 Estimation of Sparse Binary Pairwise Markov Networks using Pseudo-likelihoods. J Mach Learn Res 2009 1.70
46 Penalized classification using Fisher's linear discriminant. J R Stat Soc Series B Stat Methodol 2011 1.69
47 Hybrid hierarchical clustering with applications to microarray data. Biostatistics 2005 1.56
48 IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J Clin Invest 2008 1.55
49 An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML. Blood 2008 1.51
50 Efficient quadratic regularization for expression arrays. Biostatistics 2004 1.50
51 Survival analysis with high-dimensional covariates. Stat Methods Med Res 2009 1.50
52 Genomics of childhood leukemias: the virtue of complexity. J Clin Oncol 2008 1.48
53 HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma. Blood 2003 1.47
54 Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes. Blood 2004 1.41
55 Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. Proc Natl Acad Sci U S A 2004 1.39
56 Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2007 1.36
57 Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease. Physiol Genomics 2005 1.22
58 Immune signatures in follicular lymphoma. N Engl J Med 2005 1.18
59 Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 2003 1.16
60 Flawed analysis, implausible results--move on. CMAJ 2004 1.14
61 Disease-specific genomic analysis: identifying the signature of pathologic biology. Bioinformatics 2007 1.12
62 Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression. Blood 2009 1.11
63 Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma. Blood 2009 1.08
64 Adaptive index models for marker-based risk stratification. Biostatistics 2010 1.07
65 DR-Integrator: a new analytic tool for integrating DNA copy number and gene expression data. Bioinformatics 2009 1.05
66 Temporal changes in gene expression induced by sulforaphane in human prostate cancer cells. Prostate 2009 1.04
67 Complementary hierarchical clustering. Biostatistics 2007 1.04
68 Mouse strain-specific differences in vascular wall gene expression and their relationship to vascular disease. Arterioscler Thromb Vasc Biol 2004 0.99
69 The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clin Cancer Res 2004 0.99
70 hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature. Am J Surg Pathol 2008 0.98
71 Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures. Proc Natl Acad Sci U S A 2005 0.95
72 A fused lasso latent feature model for analyzing multi-sample aCGH data. Biostatistics 2011 0.94
73 Cancer characterization and feature set extraction by discriminative margin clustering. BMC Bioinformatics 2004 0.94
74 A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions. Genome Biol 2014 0.91
75 Scientific research in the age of omics: the good, the bad, and the sloppy. J Am Med Inform Assoc 2012 0.91
76 TESTING SIGNIFICANCE OF FEATURES BY LASSOED PRINCIPAL COMPONENTS. Ann Appl Stat 2008 0.87
77 A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era. Br J Haematol 2014 0.86
78 Alteration of gene expression signatures of cortical differentiation and wound response in lethal clear cell renal cell carcinomas. PLoS One 2009 0.86
79 Bayesian gene set analysis for identifying significant biological pathways. J R Stat Soc Ser C Appl Stat 2011 0.84
80 CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas. Hum Pathol 2009 0.83
81 Local false discovery rate facilitates comparison of different microarray experiments. Nucleic Acids Res 2009 0.81
82 Molecular subtyping for clinically defined breast cancer subgroups. Breast Cancer Res 2015 0.80
83 Classification of patients from time-course gene expression. Biostatistics 2012 0.79
84 C-C chemokine receptor 1 expression in human hematolymphoid neoplasia. Am J Clin Pathol 2010 0.78
85 QnAs with Robert Tibshirani. Proc Natl Acad Sci U S A 2015 0.75
86 SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness. medRxiv 2020 0.75
87 Corrigendum: Landscape of monoallelic DNA accessibility in mouse embryonic stem cells and neural progenitor cells. Nat Genet 2017 0.75